Physician profile
Adrian M Danchenko
NPI 1124027230
$1,414.43
in general payments reported to CMS, 2019-2025
19 companies · $80.11 in 2025
The $80.11 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.38 · 2021: $292 · 2022: $521 · 2023: $265 · 2024: $227 · 2025: $80.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $244.00 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $176.30 | 2020-2023 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $173.21 | 2021-2023 | |
| Boston Scientific Corporation | $120.74 | 2021-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $106.49 | 2021-2023 | Eliquis |
| Pfizer INC. | $92.19 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.49 | 2021-2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $73.20 | 2024 | Amvuttra |
| Janssen Pharmaceuticals, INC | $62.95 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $60.19 | 2022 | |
| Vital Connect, INC | $43.85 | 2022-2023 | Vitalpatch Rtm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.36 | 2021-2025 | Lifevest |
| Genzyme Corporation | $25.18 | 2023 | |
| Heartflow, INC. | $22.49 | 2025 | |
| Sanofi-Aventis U.S. LLC | $20.75 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.96 | 2020 | |
| Abiomed | $17.07 | 2024 | Impella |
| Arbor Pharmaceuticals, INC. | $15.37 | 2021 | |
| Fujifilm Healthcare Americas Corporation | $14.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Danchenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.